The S&P 500 and Nasdaq each set intraday records on Friday, but a majority of stocks were actually falling. The S&P 500 was up 0.7% after setting an intraday record at 7164.45. The Nasdaq was up 1.5% ...

Market breadth, which measures how many stocks are participating in a move, is at a multi-year low. The recent surge to record highs has been driven by a small group of companies. Whether that's good ...

Bankrupt auto-parts maker First Brands Group must give a last-minute bidder a chance to buy some of its most-recognizable brands, a federal judge ruled Tuesday. Autoparts maker NOCO Co. has until ...

What’s unusual today is the degree of divergence between individual stocks and the cap-weighted index. The single most damaging decision most investors make during periods of falling stock market ...

Add Yahoo as a preferred source to see more of our stories on Google. Spring has sprung at Endless View Farms in Crimora with tulips starting to bloom and the operation's annual Spring Festival ...

Builders FirstSource CEO Peter Jackson said the company is positioning itself as a full-service partner for homebuilders through acquisitions, installation services, and the myBLDR digital portal. BFS ...

Kyle Kirkwood keeps taking it to the streets in IndyCar, and this time he won a new race to take over the series lead. Kirkwood made an aggressive pass below four-time series champion Alex Palou with ...

A long-awaited Medicare add-on billing code not only boosted pay for primary care physicians but also helped specialists, researchers found in a new JAMA study that’s likely to reignite debate over ...

OpenAI on Thursday launched GPT-5.3-Codex-Spark, a stripped-down coding model engineered for near-instantaneous response times, marking the company's first significant inference partnership outside ...

The California Housing Finance Authority is relaunching its Dream For All program on Feb. 24, which offers first-time homebuyers up to 20% of a home's purchasing price to assist with closing and ...

(RTTNews) - Kymera Therapeutics, Inc. (KYMR) announced that the first patient has been dosed in its BREADTH Phase 2b clinical trial evaluating KT-621, an oral, highly selective degrader of STAT6, in ...